Ophthalmology in Tennessee

BlephEx, LLC manufactures and markets BlephEx®, a specialized in-office eyelid cleaning procedure system designed to treat dry eye and blepharitis. The BlephEx® procedure is a non-invasive, doctor-performed treatment that safely removes bacteria, debris, biofilm, and excess oils from eyelid margins and the base of eyelashes. The procedure addresses root causes of eyelid symptoms including irritation, redness, and ocular surface discomfort by promoting professional eyelid hygiene and maintaining a clean, healthy lid margin environment. BlephEx® is a quick, painless, and comfortable procedure suitable for comprehensive eye care routines. The company also offers LashCam®, a high-resolution WIFI-enabled diagnostic camera with 80X magnification that allows ophthalmologists and optometrists to visualize eyelid margin conditions in detail, enabling patient education regarding bacterial biofilm, debris accumulation, and the clinical rationale for BlephEx® treatment. LashCam® captures images compatible with iOS and Android devices, facilitating real-time visualization during patient examinations. BlephEx targets eye care practitioners, ophthalmologists, and optometrists seeking to expand dry eye and anterior segment disease treatment capabilities. The company positions BlephEx® as the first and only doctor-performed eyelid cleaning procedure for professional lid margin maintenance.

Omni Lens Pvt. Ltd. is one of India's largest manufacturers of intraocular lenses (IOLs) and comprehensive cataract surgery solutions. Established in the early 1990s, the company supplies a complete portfolio of IOL technologies including monofocal, multifocal, toric, EDOF, and aspheric designs available in both hydrophilic and hydrophobic platforms. Core product lines include Acrivue (hydrophobic), Gennext and Innova aspheric ranges, Aquafold basic hydrophilic IOLs, Revive multifocal IOLs, and Axis Toric IOLs. The company also manufactures viscoelastic agents (OMNI VISC, OMNI HYAL), ophthalmic solutions (OMNI Chol, OMNI Blue, Brilliant Blue trypan blue), and consumables including capsulorhexis rings, injectors, ophthalmic knives, sponges, diagnostic strips, and surgical drapes. ISO 13485 and CE-certified, Omni Lens exports to over 90 countries and maintains 70% export orientation. The company operates as both a branded manufacturer and OEM partner for ophthalmic device companies, with experienced production, quality control, and regulatory teams. Products are designed for cataract surgery in diverse clinical settings and patient populations, from standard cases to premium toric and multifocal corrections.

Ophthalmic Solution, Inc. (OSI) is a US-based manufacturer of intraocular lenses (IOLs) founded in 2009 and headquartered in Knoxville, Tennessee. OSI specializes in the design and production of premium IOLs for cataract surgery, including monofocal, multifocal, toric, and trifocal options. The company manufactures IOLs using both hydrophilic and hydrophobic acrylic materials, engineered to correct corneal astigmatism, spherical aberrations, and presbyopia. All IOL designs incorporate advanced optical engineering to deliver superior visual outcomes for patients undergoing cataract procedures. OSI is recognized for high-quality manufacturing, clinical reliability, and responsive customer service to ophthalmic surgeons and surgical centers.

Cumberland Biotherapeutics is a privately held biopharmaceutical company headquartered in Sewanee, Tennessee, founded in 2020. The company develops and commercializes bioceutical and phytotherapeutic products that combine modern clinical research with botanical science to address unmet medical needs. The company's commercial product portfolio includes DentoClude™ F, an FDA-registered in-office dental desensitizing device formulated with submicron bioactive glass, fluoride, and botanical extracts designed to block dentin tubules and relieve tooth sensitivity; and LigoFlex ES, a joint and inflammation support product formulated as a plant-based COX-2 inhibitor for rheumatoid arthritis, osteoarthritis, and mobility support. Cumberland Biotherapeutics integrates Ayurvedic medicine principles with rigorous scientific validation across research-driven formulation, botanical expertise, and patient-centered development. The company's pipeline includes additional bioceutical therapies in oral health, joint health, systemic and localized inflammation, and wellness/preventive health applications. The company markets products to dental professionals, healthcare providers, and potential distribution and research partners.